login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RELAY THERAPEUTICS INC (RLAY) Stock News
USA
- NASDAQ:RLAY -
US75943R1023
-
Common Stock
6.1
USD
-0.43 (-6.58%)
Last: 11/7/2025, 3:36:37 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RLAY Latest News, Press Relases and Analysis
All
Press Releases
21 hours ago - By: Chartmill
Relay Therapeutics Inc (NASDAQ:RLAY) Reports Q3 2025 Earnings Miss and Clinical Progress
a day ago - By: Relay Therapeutics, Inc.
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
a day ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
4 days ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
8 days ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
8 days ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
8 days ago - By: Zacks Investment Research
Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a Bet
2 months ago - By: Zacks Investment Research
- Mentions:
ALLO
BMY
PFE
LLY
...
Investing in Oncology: 3 Cancer Stocks With Promising Pipelines
2 months ago - By: The Motley Fool
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week
2 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
2 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
3 months ago - By: Zacks Investment Research
Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock?
3 months ago - By: Zacks Investment Research
- Mentions:
PROF
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: The Motley Fool
Relay (RLAY) Q2 Loss Narrows 41%
3 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
3 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
3 months ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
3 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
3 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
4 months ago - By: Zacks Investment Research
- Mentions:
SDGR
RXRX
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
4 months ago - By: Zacks Investment Research
- Mentions:
SDGR
RXRX
Will RXRX's Shift in Pipeline Focus Help Restore Investor Faith?
5 months ago - By: Yahoo Finance
- Mentions:
BAC
SANA
BofA Remains Bullish on Sana Biotechnology (SANA)
5 months ago - By: Relay Therapeutics, Inc.
- Mentions:
BCAX
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
5 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
5 months ago - By: Yahoo Finance
- Mentions:
RNA
AAPL
GOOG
Avidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease Trial
5 months ago - By: Yahoo Finance
- Mentions:
AAPL
GOOG
Relay Therapeutics, Inc. (RLAY): A Bull Case Theory
5 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
5 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
5 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
5 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
6 months ago - By: Zacks Investment Research
What Makes Relay Therapeutics (RLAY) a New Buy Stock
6 months ago - By: Yahoo Finance
Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now
6 months ago - By: Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Please enable JavaScript to continue using this application.